Search “is cord blood banking a scam” and you will find doctors, science writers and national health services arguing that private banking is oversold. Search a cord blood bank’s website and you will find the opposite. Both cannot be right.
This guide works through six claims parents encounter most often and sets each against the published evidence, including the parts that do not favour us. We are a cord blood bank. You should read what follows knowing that, and check the sources at the end.

Fact: cord blood is an established treatment for around 80 blood, immune and metabolic conditions. Everything beyond that list is still research.
Cord blood stem cells are standard therapy for conditions including leukaemia, lymphoma, thalassaemia, sickle cell disease, aplastic anaemia and a range of inherited immune and metabolic disorders. That is a genuinely serious list and it is not in dispute.
Cerebral palsy, autism and type 1 diabetes are different. Cord blood is being studied in clinical trials for all three. None is an approved treatment, and a trial result is not a therapy. Any bank presenting these as near-certain future uses is describing hope, not medicine.
There is a harder fact that most banks leave out. A child’s own cord blood cannot be used to treat that child’s genetic disease, and is generally not used to treat that child’s leukaemia. The American College of Obstetricians and Gynecologists explains why: the stored cells carry the same genetic variant, or the same pre-malignant cells, that caused the illness. This matters because it means the real value of a stored unit is usually for a sibling or a matched relative, not for the child it came from.
Fact: for a healthy child with no family history, the odds of use are low. How low is genuinely contested, and anyone quoting you a single confident number is selling something.
Published estimates sit a long way apart, because they measure different things:
Read together, the honest summary is this: your child is unlikely to need their own unit, more likely to need some form of transplant at some point in a long life, and most likely of all to benefit from a matched donor rather than themselves.
Where the value is real and not statistical:
That last point is the one most often missed. The medical guidance you will read online is not wrong, but it was written for a different population than the one delivering in Abu Dhabi.

Fact: it has been expensive in the UAE, and that is a fair criticism of the market. Price varies by a factor of five between providers for a broadly similar service.
Aletihad reported private cord blood banking in the UAE costing between AED 20,000 and AED 38,000. At those prices the scepticism is understandable. Abu Dhabi Biobank charges from AED 7,500 inclusive of VAT for 30 years of storage, with two higher tiers for families who want worldwide shipping or priority services. Our full pricing breakdown sets out what each plan includes.
What a legitimate fee actually pays for:
The test of a money grab is not the size of the fee. It is whether the provider will tell you the fee before you speak to a salesperson. Most UAE banks still will not publish a price.
Fact: almost certainly not. Elective private storage is not a treatment, and UAE health plans cover treatment.
Private cord blood banking is a preventive, elective service chosen by the parent. It does not appear as a listed benefit in the DHA Essential Benefits Plan or in standard Abu Dhabi basic plan schedules, and most policies exclude elective and non-medically-necessary procedures as a matter of course.
The narrow exception is where cord blood is collected because a named family member has a documented condition and a clinician has requested it as part of a treatment plan. That is a medical indication rather than elective storage, and it should be discussed with your insurer and your obstetrician in advance rather than assumed.
Check your own policy schedule before you budget. Do not rely on a bank, including this one, to tell you what your insurer covers.
Fact: they are different products with different owners, and for most families the medical societies recommend donation.
Donate to a public bank and the unit enters a registry available to any matched patient worldwide. You give up ownership. It is free, and it is what ACOG and the American Academy of Pediatrics recommend as the default for families with no known medical indication.
Bank privately and the unit is reserved for your child and matched close family. You pay, and you keep control.
A hybrid bank offers both under one licence and one quality system. Abu Dhabi Biobank runs public banking and private banking from the same laboratory, which means choosing to donate does not mean choosing a different provider or a lower standard of processing.

Fact: this is the myth that actually costs families money. Banks differ on the things that determine whether a unit is usable decades later.
Four checks separate a compliant provider from a marketing operation:
Our guide to UAE cord blood banking laws and DoH licensing [LINK PENDING: publish article one first, then link here] explains each requirement and where it comes from. You can also review our clinical leadership team and the hospitals we collect from .
Cord blood banking is not a scam. It is also not the insurance policy the marketing implies. It is a low-probability, high-consequence hedge whose value depends almost entirely on your family history and your genetic background, and which is worth materially more to some UAE families than the international guidance suggests.
If you have a family history of a blood disorder, or you carry a thalassaemia or sickle cell trait, discuss it with your obstetrician. If you do not, public donation is a reasonable and generous default. Either way, choose a licensed bank that stores inside the UAE and publishes its prices. You can speak to our medical advisors or review what cord blood banking involves before you decide.
No, but some marketing around it is misleading. Cord blood is established treatment for around 80 conditions. Claims that it treats autism, cerebral palsy or diabetes describe clinical trials, not approved therapies. Judge a bank by whether it publishes prices, names its licence and states the limitations honestly.
Estimates vary widely. The American Academy of Pediatrics cites 1 in 200,000 for a child using their own unit. The chance of needing any stem cell transplant across a 70-year life is closer to 1 in 200. Odds rise significantly with a known family history or a sibling in need.
Generally no. Elective private storage is not a treatment and does not appear as a listed benefit in standard UAE plan schedules. Coverage is only realistic where a clinician has requested collection for a documented family medical indication. Check your policy schedule directly rather than assuming.
For families with no known medical indication, ACOG and the American Academy of Pediatrics recommend public donation. It is free and the unit helps whoever matches. Private banking reserves the unit for your family and is supported where a relative has a condition treatable by transplant.
Historically it has been. Aletihad reported UAE prices between AED 20,000 and AED 38,000. The fee covers collection, maternal screening, transplant-grade processing, viability testing and decades of monitored cryogenic storage. Prices now vary by a factor of five between UAE providers for broadly similar services.
Check four things: a licence from the health authority in the emirate where you deliver, accreditation from AABB, FACT or JACIE with a date, a laboratory and storage facility inside the UAE, and a published all-in price. A provider unwilling to give any of these in writing has answered you.